Diabetologia

, Volume 55, Issue 12, pp 3401–3401

Erratum to: Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse

  • D. Bobbala
  • X.-L. Chen
  • C. Leblanc
  • M. Mayhue
  • J. Stankova
  • T. Tanaka
  • Y.-G. Chen
  • S. Ilangumaran
  • S. Ramanathan
Erratum

DOI: 10.1007/s00125-012-2739-2

Cite this article as:
Bobbala, D., Chen, XL., Leblanc, C. et al. Diabetologia (2012) 55: 3401. doi:10.1007/s00125-012-2739-2

Erratum to: Diabetologia

DOI 10.1007/s00125-012-2675-1

Unfortunately there was a mistake in Fig. 6a which made it appear as though the results for the mice injected with control mAb did not start at 100%. The corrected graph is shown here.
https://static-content.springer.com/image/art%3A10.1007%2Fs00125-012-2739-2/MediaObjects/125_2012_2739_Fig1_HTML.gif
Fig. 6

Inhibition of IL-15 signalling in NOD mice decreases type 1 diabetes. (a) Female NOD mice were administered, by i.p. injection, 200 μg TM-β1 mAb (white circles, n = 12) or control mAb (black circles, n = 8) three times a week for 4 weeks (indicated by the grey bar). Injected mice were followed for diabetes development up to 7 months of age. Data from mice from two different experiments were pooled. p < 0.01 (logrank test)

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • D. Bobbala
    • 1
  • X.-L. Chen
    • 1
  • C. Leblanc
    • 1
  • M. Mayhue
    • 1
  • J. Stankova
    • 1
    • 2
  • T. Tanaka
    • 3
  • Y.-G. Chen
    • 4
  • S. Ilangumaran
    • 1
    • 2
  • S. Ramanathan
    • 1
    • 2
  1. 1.CRC 4855, Immunology Division, Department of PediatricsFaculty of Medicine and Health SciencesSherbrookeCanada
  2. 2.Centre de Recherche Clinique Etienne-Le BelSherbrookeCanada
  3. 3.Hyogo University of Health Sciences, School of PharmacyKobeJapan
  4. 4.Department of Pediatrics, Max McGee National Research Center for Juvenile DiabetesMedical College of WisconsinMilwaukeeUSA